A Study of Pembrolizumab and Cryoablation in People With Breast Cancer

A Study of Pembrolizumab and Cryoablation in People With Breast Cancer
Conditions: Metastatic Breast Cancer; Breast Cancer; Breast Cancer Stage IV; Triple Negative Breast Cancer; Triple Negative Breast Neoplasms; Metastatic Triple-Negative Breast Carcinoma; Locally Advanced Breast Cancer; Locally Advanced Triple-Negative Breast Carcinoma

Interventions: Drug: Pembrolizumab; Device: Cryoablation

Sponsors: Memorial Sloan Kettering Cancer Center

**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

February 8, 2024Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments